MeMed
To improve people’s lives through innovative host immune response technology and to solve problems that do not have resolution in 21st century medicine.
MeMed Key
The Compact Immunoassay Platform
MeMed Key is a cutting edge, compact immunoassay platform that makes it possible to conduct highly sensitive, rapid, multiplexed protein measurements that previously could only be done on large, expensive central lab equipment.
MeMed BV
Rapidly diagnose infection etiology Powered by Host Response.
Is it bacterial or viral?
Bacterial and viral infections often present with similar symptoms, making treatment decisions difficult.
MeMed BV uses host response data to quickly and accurately differentiate between them—empowering physicians to make faster, more informed choices and reduce unnecessary antibiotic use.
Antibiotic Mis-use Is Often a Result of Diagnostic Uncertainty
40%
Antibiotic overuse 1
20%
Antibiotic underuse 2
15 Minutes to Clinical Certainty
- Three Biomarkers: Our platform simultaneously measures TRAIL, IP-10, and CRP 3 host-response proteins whose combination provides a comprehensive immune signature.
- Definitive Differentiation: Unlike single-marker tests, MeMed BV harnesses the unique behavior of proteins that are both viral-sensitive and bacterial-specific, delivering clear clarity in just 15 minutes.
- FDA-Cleared Accuracy, Proven at the Point of Care: Bring advanced laboratory precision. Make data-driven decisions that enable proper antibiotic stewardship.
97%
AUC
MeMed BV Performance
MeMed BV performance has been independently confirmed through blinded validation and real-world evidence across more than 20,000 patients.
The FDA clinical study (Apollo) was conducted to establish the diagnostic performance of the MeMed BV test for differentiating bacterial from viral infection in patients with suspected acute bacterial or viral infection.
Consistent Accuracy Across Settings and Populations.
Our unique emphasis on quality and breadth of clinical evidence sets MeMed apart.
MeMed BV performance has been validated in multi-national, double-blind clinical studies and real world settings in Europe, Israel and the United States. These studies have consistently demonstrated compelling performance results in different clinical settings, age groups, and patients with different clinical syndromes.
CONTACT NOW
Are you interested in the product?
We’d love to hear from you. Get in touch with us just below to request an offer!